4-Anilino-3-quinolinecarbonitriles: An Emerging Class of Kinase Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|2|9|1051-1063

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.2, Iss.9, 2002-09, pp. : 1051-1063

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

4-Anilino-3-quinolinecarbonitriles: An Emerging Class of Kinase Inhibitors - An Update

By  

Medicinal Chemistry Reviews - Online, Vol. 1, Iss. 4, 2004-10 ,pp. : 457-463

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging Flt3 kinase inhibitors in the treatment of leukaemia

By Tickenbrock Lara   Müller-Tidow Carsten   Berdel Wolfgang E   Serve Hubert  

Expert Opinion on Emerging Drugs, Vol. 11, Iss. 1, 2006-03 ,pp. : 153-165

Informa Healthcare

Access to resources Recommend Favorite

Advances in the Development of Class I Phosphoinositide 3-Kinase (PI3K) Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 13, 2016-05 ,pp. : 1413-1426

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in the Preclinical Discovery and Clinical Development of Class I and Dual Class I/IV Phosphoinositide 3-Kinase (PI3K) Inhibitors

By  

Current Medicinal Chemistry, Vol. 18, Iss. 18, 2011-06 ,pp. : 2686-2714

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging FMS-like tyrosine kinase 3 inhibitors for the treatment of acute myelogenous leukemia

By Prescott Hillary   Kantarjian Hagop   Cortes Jorge   Ravandi Farhad  

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 3, 2011-09 ,pp. : 407-423

Informa Healthcare

Access to resources Recommend Favorite